Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2014   |   Volume: 3   |   Issue: 3   |   Page: 196-199     View issue

Post-operative adjuvant treatment in carcinoma gall bladder: A brief review


, , , , , ,
Abstract

Gallbladder cancer (GBC) represents the most common malignancy among the biliary tree cancers representing 3% of such tumors. Complete surgical resection offers the best chance for cure. Adjuvant chemotherapy and radiotherapy are less well-defined and need to be further evaluated to increase local and systemic control. Local recurrences as high as 75% have been reported after radical cholecystectomy in GBC. The patterns of failure and poor overall prognosis in GBC, justify administration of adjuvant treatments. Only an estimated 20% of patients receive radiotherapy or chemotherapy after resection and fewer than 10% of all presenting patients undergo surgery, radiotherapy and chemotherapy. Recent series have suggested that local-regional control and possibly ultimate outcome can be improved by the use of adjuvant therapy.

Cite this article
Vancouver
Singh P, Kapoor R, Kumar R, Bahl A, Kumar N, Gupta R, et al. Post-operative adjuvant treatment in carcinoma gall bladder: A brief review. Clin Cancer Investig J. 2014;3(3):196-9. https://doi.org/10.4103/2278-0513.132108
APA
Singh, P., Kapoor, R., Kumar, R., Bahl, A., Kumar, N., Gupta, R., & Sharma, S. (2014). Post-operative adjuvant treatment in carcinoma gall bladder: A brief review. Clinical Cancer Investigation Journal, 3(3), 196-199. https://doi.org/10.4103/2278-0513.132108

© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513